Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
CVS Pharmacy Settlement Results in $650K Payment, Improved Oversight March 5, 2013 Irvin Jackson Add Your Comments CVS has agreed to pay $650,000 and promised to improve the quality of oversight to settle claims brought by the state of New Jersey, which alleged that the pharmacy repeatedly gave patients the wrong drugs, sometimes placing them in danger. The allegations stem from an investigation by the New Jersey Division of Consumer Affairs, which announced the agreement in a press release on February 25. According to a report by the agency, dozens of prescription errors were made at five CVS pharmacy locations in New Jersey, including Budd Lake, Chatham, Cherry Hill, Rahway, and Scotch Plains. Learn More About Risperdal Lawsuits Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Risperdal Lawsuits Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia. Learn More SEE IF YOU QUALIFY FOR COMPENSATION A prescription error at a Chatham CVS led to the initial investigation. According to the state’s review, the CVS pharmacy at 471 Main Street in Chatham distributed 15 prescription bottles of fluoride pills for children that also included Tamoxifen, a breast cancer drug that can cause cognitive problems and memory loss. The medication mistakes occurred between December 20, 2011 and February 20, 2012. “The Division of Consumer Affairs launched an immediate inquiry to ascertain the facts, and potential harm to consumers, of a pill dispensing error at the CVS in Chatham – and soon learned about similar incidents at a total of five CVS pharmacies across New Jersey, all within a short span of time,” Attorney General Jeffrey Chiesa said in the press release. “In order to protect the public and prevent these errors from happening again, the Division pushed CVS to work with us on an effective solution.” Other New Jersey CVS drug mix-ups included putting pills for the high blood pressure drug metoprolol into bottles with Risperdal, an antipsychotic; and giving a patient the cholesterol drug pravastatin when they were supposed to receive the diabetes drug metaformin. In addition to agreeing to pay $650,000, CVS has promised to retrain staff at all of its New Jersey pharmacies, create new procedures for using automated filling machines to fill prescriptions and put into place other new quality assurance measures. The company’s $650,000 will fund a public awareness campaign in New Jersey on the dangers of prescription drug abuse and the proper use of prescription drugs, and repays the state the cost of the investigation. Tags: CVS, Medication Error, New Jersey, Pharmacy Error, Prescription Mistake, Risperdal, Tamoxifen More Risperdal Lawsuit Stories Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022 Breast Cancer Side Effects Linked to Antipsychotic Medications: Study December 9, 2021 $70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review May 18, 2021 2 Comments Chiara May 22, 2023 What good did the 650k for oversight do when as of today there still withholding another medication and charging the insurance company for the medication and trying to substitute it with a medication that can my daughter an adverse effect and she cannot take because it interacts with the medications shes on and its deadly.YOU GAVE THEM CVS TILL JUNE 23 OF 2023 TO FIX THE PROBLEM WELL ITS LIKE YOU GOT WHAT YOU WANT AND ARE NOT FIXING THE PROBLEM YOUR HELPING YOURSELF.I HAVE 1 DAY OR SHE TO BE HOSPITALIZED AND SUPERVISED AND YOUR PLAYING WITH PEOPLES LIVES. chiara April 23, 2023 My Issue is that I have been traumatized by CVS.My daughter takes 30 pills a day as is alive today because of these medications but as of lately a few months or longer they have been not able to get her meds,say they need prior authorization when done by the doctors at least three times where oops where sorry it was authorized.Then giving me labels written incorrectly,over billing medicaid by giving 2 tablets 1x a day for 30 days with only 8 tablets for 4 days with 27 refills charging 112.$ so figure it out.They dont have the medication in stock although using the same cvs for 20 years and she is on ready fill THEY ABSOLUTELY ARE ENDANGERING THE WELFARE OF A PERSON AND A DISABLED PERSON LIFE IT IS LIFE OR DEATH SHE IS EPILEPTIC AND ASTHMATIC.THERE MORE TO THIS STORY. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022
$70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review May 18, 2021
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)